Russ Lebovitz
Global Venture Partner at BootstrapLabs
San Francisco, California
Overview
Work Experience
CEO
2007 - Current
Amprion focuses on highly sensitive, early detection of misfolded prion proteins responsible for progressive neurodegeneration in Alzheimer's, Parkinson's and other CNS degenerative diseases. Amprion's mission is to end Alzheimer's and Parkinson's through early molecular detection plus accelerated development of effective treatments.
Amprion is a biotech company that focuses on the diagnosis for brain diseases.
Raised $17,056,960.00 from Propel(X), Eli Lilly and Formation Venture Engineering.
Director
2013
Leading a focused team of multi-talented & highly experienced cosmetic, scientific and medical professionals through development, marketing and sales of highly novel, proprietary products to dramatically improve the appearance of age and sun-damaged skin.
A Scientifically Proven & Patented Formula for Skin Resurfacing
Global Venture Partner
2016
BootstrapLabs is a leading Venture Capital firm based in Silicon Valley and focused on Applied Artificial Intelligence
Managing Partner
1996
Suma Ventures identifies emerging growth areas in the life sciences and cleantech industries and partners with leading universities and entrepreneurs to create and grow substantive companies in these areas.
Director
2017 - 2022
Ambra BioScience is focused on improving our understanding of the complex relationship between nutrition, digestion and health.
Ambra BioScience LLC - Lovidia is a proprietary gut sensory modulation technology platform.
Raised $2,215,000.00.
President & CEO
2006 - 2012
Marval is developing next-generation contrast agents with enhanced efficacy, function and safety for CT and XRay applications.
President/CEO
2006 - 2008
Early-stage MRI contrast-agent development company.
President/CEO
2003 - 2006
Managed fundraising, M&A activiities and joint venture relationships with large pharma partners.